By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



3388 Mike Collins Drive

Eagan  Minnesota  55121  U.S.A.
Phone: 651-675-0300 Fax: 651-675-0400



Company News
Biothera’s Imprime PGG And Anti-Angiogenic Antibodies Work In Concert To Re-Orient The Immune Microenvironment To Support Cancer Killing, Study Finds 11/6/2015 8:09:11 AM
Biothera's Imprime PGG And Monoclonal Antibody Therapy Alleviates Immune Suppression In Tumor Microenvironment And Increases Cancer Cell Killing 11/6/2015 8:08:12 AM
Biothera To Present Three Abstracts At AACR-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer Therapeutics 11/2/2015 10:00:27 AM
Biothera Appoints Dr. Jose Iglesias As Chief Medical Officer 10/15/2015 10:57:49 AM
Biothera’s Cancer Immunotherapy Drug Imprime PGG Elicits Increased Natural Killer Cell Activation And Cancer Cell Killing 9/18/2015 9:13:40 AM
Biothera’s Imprime PGG Cancer Immunotherapy Drug Activates Dendritic Cells, Leading To Enhanced T Cell Expansion And Cytokine Production 9/18/2015 7:36:45 AM
Biothera To Present New Data At International Cancer Immunotherapy Conference 9/1/2015 9:28:38 AM
Cancer Research UK Funding Preclinical Study With Biothera’s Imprime PGG in Combination Therapy 8/18/2015 10:17:07 AM
Investigator-Sponsored Trial Evaluating Biothera’s Imprime PGG In Relapsed Indolent Non-Hodgkin Lymphoma 6/22/2015 11:56:47 AM
Biothera To Participate In Webcast On Advances In Cancer Immunotherapy 6/18/2015 11:10:32 AM